CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents ($642 and $706 related to VIEs)	$ 2,137	$ 2,439
Marketable securities ($132 and $130 related to VIEs)	174	185
Accounts receivable, net ($149 and $196 related to VIEs)	1,088	1,109
Contract assets	1,063	915
Other current assets ($25 and $30 related to VIEs)	375	396
Total current assets	4,837	5,044
Noncurrent assets
PP&E, net ($44 and $45 related to VIEs)	434	447
Investments	612	584
Deferred taxes	34	34
Deferred compensation trusts	226	234
Goodwill	206	206
Other assets ($77 and $54 related to VIEs)	281	278
Total noncurrent assets	1,793	1,783
Total assets	6,630	6,827
Current liabilities
Accounts payable ($240 and $253 related to VIEs)	1,068	1,017
Short-term debt and current portion of long-term debt	16	152
Contract liabilities ($380 and $352 related to VIEs)	765	742
Accrued salaries, wages and benefits ($22 and $24 related to VIEs)	574	626
Other accrued liabilities ($46 related to VIEs in both periods)	743	679
Total current liabilities	3,166	3,216
Long-term debt	978	978
Deferred taxes	84	73
Other noncurrent liabilities ($43 and $54 related to VIEs)	495	564
Commitments and contingencies
Shareholders’ equity
Preferred stock — authorized 20,000,000 shares ($0.01 par value); issued and outstanding —600,000 shares in 2023 and 2022	0	0
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 143,237,347 and 142,322,247 shares in 2023 and 2022, respectively	1	1
APIC	1,257	1,254
AOCI	(319)	(365)
Retained earnings	780	896
Total shareholders’ equity	1,719	1,786
NCI	188	210
Total equity	1,907	1,996
Total liabilities and equity	$ 6,630	$ 6,827